A therapy that would once have been considered a feat of science fiction has reversed aggressive and incurable blood cancers ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.

CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...

CAR7, has shown remarkable success in reversing an aggressive form of leukemia. This world-first treatment uses genetically ...

This article examines some of the cell-based approaches that researchers are using to study acquired drug resistance and the effects of specific genetic variants on cancer cell physiology.

Two studies published in Nature Medicine June 11 contribute to a small body of literature suggesting cells edited with CRISPR-Cas9 may cause cancer. Here are five things to know about the studies and ...

Prof. Lukas Dow, biochemistry, and his team published a study in Nature on Aug. 16, detailing a new, more specific gene editing tool that they created to study cancer mutations through preclinical ...

Researchers used CRISPR screening in tumor organoids and mice to identify two genes, Ctnna1 and Bcl2l13, that suppress colorectal cancer metastasis. One limits cell invasion, while the other triggers ...

Innovative therapy gives hope to patients whose blood cancer ‘seemed incurable’ - Almost two thirds of patients with T-cell ...

Gene editing strategies, from epigenetic engineering to cell reprogramming and genetic vaccines, are accelerating the development of new therapies that awaken the immune system to treat cancer, as ...